April 03, 2025

New Option for IgA Nephropathy Management

The FDA has granted accelerated approval to Vanrafia (atrasentan) for reducing proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression.

Conexiant

April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

April 01, 2025

Cemiplimab Effective for Advanced cSCC

Meta-analysis of 19 studies reveals promising 54.5% objective response rate and manageable safety profile for PD-1 inhibitor in treating advanced cutaneous squamous cell carcinoma.

Conexiant

March 27, 2025

Randomized Trial Evaluates ICG Fluorescence in Surgical Outcomes

Routine use of ICG fluorescence imaging does not significantly reduce anastomotic leak rates in colorectal surgery, though a potential benefit was observed for left-sided operations.

Conexiant

March 25, 2025

Microplastics: Chewing Gum May Release Particles Into Saliva

"Surprisingly, both synthetic and natural gums had similar amounts of microplastics released when we chewed them."

Conexiant

March 12, 2025

A Firm Pigmented Plaque on the Forearm of a Child: What's Your Diagnosis?

Rare pediatric Bednar tumor case highlights importance of histopathology and molecular testing in distinguishing uncommon dermatologic malignancies from benign pigmented lesions

Conexiant

March 07, 2025

What's Your Diagnosis? Persistent Sore Throat and Lymphadenopathy in a 67-Year-Old Man

A 67-year-old man's secondary syphilis was diagnosed nearly a year after presenting with persistent sore throat and swollen lymph nodes.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 05, 2025

FDA Monthly Round-Up: Key February Updates

February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.

Conexiant